semaglutide abuse A South African court has ordered pharmacy group iDexis to stop selling semaglutide-based medicines. The ruling follows a legal challenge by Novo Nordisk, maker of Ozempic and Wegovy. Novo alleged the company Weight-loss drugs are becoming more
Description
With the Wegovy pill now approved by the UK's medicines regulator, women now have more options than ever before to help them lose weight
avg body weight lost with Semaglutide (NEJM STEP 1 trial, 68 weeks) 2025% avg body weight lost with Tirzepatide (SURMOUNT-1, 7288 weeks) of semaglutide patients lost 5% of body weight (STEP 1 trial)of semaglutide patients lost 5% of body weight (STEP 1 trial) Week 14: Appetite reduction, smaller portions naturally Month 13: Steady fat loss begins, 12 lbs/week avg Month 36: Visible body composition change, reduced visceral fat 68 weeks: Average 14.9% total body weight reduction Ozempic for weight loss and Wegovy for weight loss produce comparable outcomes at equivalent doses
By slowing digestion and reducing cravings, it may help support steady weight management alongside diet and exercise
Maintain regular check-ins with both your psychiatrist and your weight loss provider to catch any shifts early
But did you know that your body naturally produces GLP-1
